112 related articles for article (PubMed ID: 22687416)
21. Effects of organic anions and bile acids on biliary lipid excretion in hyperbilirubinemic mutant Sprague-Dawley rats.
Takikawa H; Sano N; Wako Y; Yamanaka M
J Hepatol; 1993 Feb; 17(2):247-52. PubMed ID: 8445239
[TBL] [Abstract][Full Text] [Related]
22. Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent.
Murata M; Tamai I; Sai Y; Nagata O; Kato H; Sugiyama Y; Tsuji A
Drug Metab Dispos; 1998 Nov; 26(11):1113-9. PubMed ID: 9806954
[TBL] [Abstract][Full Text] [Related]
23. Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats.
Chu XY; Kato Y; Niinuma K; Sudo KI; Hakusui H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Apr; 281(1):304-14. PubMed ID: 9103511
[TBL] [Abstract][Full Text] [Related]
24. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
Takenaka O; Horie T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1995 Sep; 274(3):1362-9. PubMed ID: 7562509
[TBL] [Abstract][Full Text] [Related]
25. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
[TBL] [Abstract][Full Text] [Related]
26. Enhanced biliary excretion of lithocholate-3-sulfate by ursodeoxycholate-3,7-disulfate infusion in Eisai hyperbilirubinemic rat (EHBR).
Takikawa H; Sano N; Ogasawara T; Yamanaka M
Dig Dis Sci; 1998 Jan; 43(1):188-92. PubMed ID: 9508524
[TBL] [Abstract][Full Text] [Related]
27. Recommendation to Exclude Bile-Duct-Cannulated Rats with Hyperbilirubinemia for Proper Conduct of Biliary Drug Excretion Studies.
Kato K; Hasegawa Y; Iwata K; Ichikawa T; Yahara T; Tsuji S; Sugiura M; Yamaguchi J
Drug Metab Dispos; 2016 Aug; 44(8):1180-3. PubMed ID: 27208382
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic study of the hepatobiliary transport of indomethacin.
Kouzuki H; Suzuki H; Sugiyama Y
Pharm Res; 2000 Apr; 17(4):432-8. PubMed ID: 10870987
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats.
Shingaki T; Takashima T; Ijuin R; Zhang X; Onoue T; Katayama Y; Okauchi T; Hayashinaka E; Cui Y; Wada Y; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
J Pharmacol Exp Ther; 2013 Oct; 347(1):193-202. PubMed ID: 23926287
[TBL] [Abstract][Full Text] [Related]
30. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
Koprowski S; Sokolowski K; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
J Surg Res; 2015 Oct; 198(2):434-40. PubMed ID: 25890434
[TBL] [Abstract][Full Text] [Related]
31. Absence of drug interaction between Hwang-Ryun-Hae-Dok-Tang and phenolsulfonphthalein.
Yi HJ; Oh JH; Lee YJ
Arch Pharm Res; 2010 Dec; 33(12):2025-31. PubMed ID: 21191769
[TBL] [Abstract][Full Text] [Related]
32. Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models.
Plengsuriyakarn T; Viyanant V; Eursitthichai V; Picha P; Kupradinun P; Itharat A; Na-Bangchang K
BMC Complement Altern Med; 2012 Mar; 12():23. PubMed ID: 22448640
[TBL] [Abstract][Full Text] [Related]
33. Impaired biliary excretion and whole body elimination of methylmercury in rats with congenital defect in biliary glutathione excretion.
Ballatori N; Gatmaitan Z; Truong AT
Hepatology; 1995 Nov; 22(5):1469-73. PubMed ID: 7590665
[TBL] [Abstract][Full Text] [Related]
34. Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics.
Kato Y; Takahara S; Kato S; Kubo Y; Sai Y; Tamai I; Yabuuchi H; Tsuji A
Drug Metab Dispos; 2008 Jun; 36(6):1088-96. PubMed ID: 18339814
[TBL] [Abstract][Full Text] [Related]
35. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
Yamazaki M; Kobayashi K; Sugiyama Y
Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118
[TBL] [Abstract][Full Text] [Related]
36. Stereoselective hepatic disposition of a diastereomeric pair of alphavbeta3 antagonists in rat.
Prueksaritanont T; Xu X; Deluna P; Yamazaki M; Lin JH
Xenobiotica; 2003 Nov; 33(11):1125-37. PubMed ID: 14660176
[TBL] [Abstract][Full Text] [Related]
37. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats.
Yamazaki M; Kobayashi K; Sugiyama Y
Biopharm Drug Dispos; 1996 Nov; 17(8):645-59. PubMed ID: 8950045
[TBL] [Abstract][Full Text] [Related]
38. Comparison of urinary excretion of pravastatin and temocapril in bile duct-ligated rats and Eisai hyperbilirubinemic rats (EHBR).
Takada Y; Tachizawa H; Kurihara H; Takayanagi M; Sasamoto T; Akashi M; Aiso M; Takamori Y; Sano N; Takikawa H
J Hepatobiliary Pancreat Surg; 2004; 11(2):125-8. PubMed ID: 15127276
[TBL] [Abstract][Full Text] [Related]
39. Multidrug resistance-associated protein2 (MRP2) plays an important role in the biliary excretion of glutathione conjugates of 4-hydroxynonenal.
Ji B; Ito K; Suzuki H; Sugiyama Y; Horie T
Free Radic Biol Med; 2002 Aug; 33(3):370-8. PubMed ID: 12126759
[TBL] [Abstract][Full Text] [Related]
40. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
